Anavex Life Sciences Corp. Liquidation Value Calculator
Anavex Life Sciences Corp.
Current Price: N/A
Loading calculator data...
Advanced: All 61 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$2.64M | USD | ||
| accounts_receivable | ||||
| Other Receivables total OtherReceivables |
$700,000 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$131.75M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$131.75M | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$2.93M | USD | ||
| liabilities_total | ||||
| Liabilities total | $6.37M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
92.7M | shares | ||
Unmapped Tags (52)
| Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock | $514.65M | USD | ||
| Assets Assets | $132.99M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $200.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $92.67M | shares | ||
| Common Stock Value CommonStockValue | $93,000 | USD | ||
| Deferred Rent Credit DeferredRentCredit | $805,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $132.99M | USD | ||
| Operating Lease Cost OperatingLeaseCost | $35,000 | USD | ||
| Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities | $1.38M | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-388.13M | USD | ||
| Stockholders Equity StockholdersEquity | $126.62M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $1.11M | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $1.10M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $29.17M | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | $4.80M | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $-1.61M | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $-965,000 | USD | ||
| Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable | $35,000 | USD | ||
| Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense | $-33,000 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $36.32M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-7.15M | USD | ||
| Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment | $4.66M | USD | ||
| Share Based Compensation ShareBasedCompensation | $1.11M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | $5 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $2.13M | USD | ||
| Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet | $-5.66M | USD | ||
| Income Taxes Receivable IncomeTaxesReceivable | $844,000 | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $18,000 | USD | ||
| Interest Income Expense Net InterestIncomeExpenseNet | $1.08M | USD | ||
| Net Income Loss NetIncomeLoss | $-5.68M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $1.12M | USD | ||
| Operating Expenses OperatingExpenses | $6.78M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-6.78M | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $396,000 | USD | ||
| Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned | $30,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $4.66M | USD | ||
| Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense | $2.13M | USD | ||
| Accrued Bonuses Current AccruedBonusesCurrent | $1.23M | USD | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $10,000 | shares | ||
| Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax | $7,000 | USD | ||
| Other Income OtherIncome | $1.12M | USD | ||
| Pension Contributions PensionContributions | $25,000 | USD | ||
| Redemption Premium RedemptionPremium | $36.30M | USD | ||
| Shares Issued SharesIssued | $6.00M | shares |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.